Acupressure for Fatigue and Low Back Pain

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT02106741
Collaborator
(none)
51
1
3
36
1.4

Study Details

Study Description

Brief Summary

The purpose of this study is to compare two kinds of self-administered acupressure (relaxation acupressure and stimulating acupressure) to usual care for management of fatigue and pain in low back pain patients.

Hypothesis: Self-administered relaxation acupressure will result in improvements in fatigue and sleep quality, pain, and physical function compared to stimulating acupressure and usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Relaxation acupressure
  • Behavioral: Stimulating acupressure
N/A

Detailed Description

Acupressure is a Traditional Chinese Medicine (TCM) technique based on a philosophy similar to that of acupuncture. It involves the application of physical pressure on different acupuncture points (acupoints). One advantage of acupressure is the ability to self-administer the treatment. Acupressure is also a viable alternative to acupuncture in situations where patients: (1) cannot come to the clinic to receive an acupuncture treatment; (2) when a more frequent intervention is needed; or (3) where needle phobia or safety concerns are an issue.

The objective of this study is to evaluate the validity and feasibility of teaching acupressure interventions using an acupressure educator for the management of symptoms related to low back pain.

Specific aims:
  1. To examine the effect of 6-weeks of relaxation acupressure (RA) compared to a regime of stimulating acupressure (SA) or wait-list control (WL) on fatigue and sleep quality as assessed by Brief Fatigue Inventory and wrist-worn accelerometry (sleep efficiency).

  2. To explore the effect of 6-weeks of RA compared to a regime of SA or WL on for chronic low back pain in terms of reduced pain and improved function.

Study Design

Study Type:
Interventional
Actual Enrollment :
51 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Randomized Pilot Study of Self-Administered Acupressure for Patients With Low Back Pain
Study Start Date :
May 1, 2013
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Relaxation acupressure

Behavioral: Relaxation acupressure
The relaxation acupressure protocol will use a set of nine fixed acupoints: forehead, twixt the eyebrows (unilateral); posterior neck, behind the ears (bilateral); palmer side of hand at wrist (bilateral); inside of lower leg (bilateral); top of foot (bilateral). A trained acupressure educator will meet with each participant and demonstrate the sites and techniques for self-administered acupressure. Additionally, each participant will receive a demonstration DVD and a laminated handout detailing the locations of each acupoint. Participants will be asked to perform daily acupressure sessions using the assigned sites. Each site is stimulated for 3 minutes, and the entire session can be completed in approximately 30 minutes.

Active Comparator: Stimulating acupressure

Behavioral: Stimulating acupressure
The stimulating acupressure protocol will use a set of ten fixed acupoints: top of the head (unilateral); below the navel (unilateral); back of the hand (bilateral); outside of lower leg (bilateral); inside of lower leg (bilateral); inside of ankle (bilateral). A trained acupressure educator will meet with each participant and demonstrate the sites and techniques for self-administered acupressure. Additionally, each participant will receive a demonstration DVD and a laminated handout detailing the locations of each acupoint. Participants will be asked to perform daily acupressure sessions using the assigned sites. Each site is stimulated for 3 minutes, and the entire session can be completed in approximately 30 minutes.

No Intervention: Wait-list control

Outcome Measures

Primary Outcome Measures

  1. Fatigue severity and interference in daily activities [Week 0 (baseline) and approximately 9 weeks (follow-up)]

    Fatigue severity and interference in daily activities will be measured using the Brief Fatigue Inventory. Subjects will answer the BFI at both baseline and follow-up. To investigate a change from baseline in fatigue, the difference between the post-assessment outcomes and baseline measures will be calculated. Analyses on these differences will be performed using independent samples t-tests between treatment groups. We will also evaluate all continuous outcomes by ANCOVA, adjusting for baseline value and treatment group.

  2. Sleep quality via objectively measured sleep efficiency [Week 0 (baseline) and approximately 9 weeks (follow-up)]

    We will use wrist-worn accelerometry to assess sleep efficiency. Subjects will wear a wrist-worn accelerometer for 7 consecutive days (at baseline and follow-up) that collects in vivo sleep quality data; an accompanying logbook will be used to enhance objective data. To investigate a change from baseline in sleep efficiency, the difference between the post-assessment outcomes and baseline measures will be calculated. Analyses on these differences will be performed using independent samples t-tests between treatment groups. We will also evaluate all continuous outcomes by ANCOVA, adjusting for baseline value and treatment group.

Secondary Outcome Measures

  1. Pain severity and interference in daily activities [Week 0 (baseline) and approximately 9 weeks (follow-up)]

    Pain severity and interference in daily activities will be measured using the Brief Pain Inventory. Subjects will answer the BPI at both baseline and follow-up. To investigate a change from baseline in pain, the difference between the post-assessment outcomes and baseline measures will be calculated. Analyses on these differences will be performed using independent samples t-tests between treatment groups. We will also evaluate all continuous outcomes by ANCOVA, adjusting for baseline value and treatment group.

  2. Level of physical functioning as measured by the Roland-Morris Disability Questionnaire. [Week 0 (baseline) and approximately 9 weeks (follow-up)]

    Subjects will answer the Roland-Morris Disability Questionnaire at both baseline and follow-up. To investigate a change from baseline in physical function, the difference between the post-assessment outcomes and baseline measures will be calculated. Analyses on these differences will be performed using independent samples t-tests between treatment groups. We will also evaluate all continuous outcomes by ANCOVA, adjusting for baseline value and treatment group.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged18-65 years

  • Non-specific low back pain (either by self-report or via ICD-9 codes 724.2, 724.5, 846.0-846.9)

  • Low back pain that has persisted for at least 3 months

  • Minimum of 3/10 on the Pain Bothersome Scale

  • Minimum of 3/10 fatigue severity

  • Ambulatory with or without assistive device

  • Ability to operate the accelerometer (Actiwatch-S)

  • Stable medication regiment for the previous 2 months

  • Report of a physician's visit during the previous 24 months

  • English-speaking

Exclusion Criteria:
  • Medically unstable (acute conditions or acute presentations of chronic conditions)

  • Current pregnancy

  • Radiculopathy or report of low back pain radiating to below the knee

  • Reported history of spinal fracture, herniated lumbar disc, ankylosing spondylitis, and spinal stenosis.

  • Report of back surgery within the preceding 12 months

  • Participation in active litigation or compensation claims

  • Conditions that might confound treatment effects or interpretation of results (for example, rheumatoid arthritis, lupus)

  • Acupuncture or acupressure within the preceding 12 months

  • Report of sleep apnea

  • 2nd or 3rd shift workers or other non-traditional sleep schedules

  • Use of anti-coagulant/platelet therapy within the preceding month

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Susan L Murphy, ScD, OTR, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susan Murphy, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Michigan
ClinicalTrials.gov Identifier:
NCT02106741
Other Study ID Numbers:
  • BAK
First Posted:
Apr 8, 2014
Last Update Posted:
Oct 25, 2016
Last Verified:
Aug 1, 2015
Keywords provided by Susan Murphy, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2016